MBRX vs MS · $8.2M cap vs P/E 20, $344.27B cap
Moleculin Biotech Inc (MBRX) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported MBRX revenue for 2024-12-31 was $0. Net income was -$21.8M. MBRX currently screens at market cap $8.2M.
MS does not have a complete income-statement cache yet.
MBRX currently screens at market cap $8.2M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the MBRX and MS stock pages for the full models.
Not investment advice.